Претраживање
Приказ резултата 21-30 од 431
Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy? / Da li pentraksin -3 doprinosi sniženju koncentracije lipoproteina niske gustine i terapiji statinima?
(Pharmaceutical Association of Serbia, 2022)
Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin ...
Pharmacology of insulin / Farmakologija insulina
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
Insulin is anabolic and anti-catabolic hormone which has an important role in the metabolism of carbohydrates, proteins and lipids. In addition, insulin is the only agent used in all forms of diabetes mellitus for blood ...
Characteristics and application of chitosan in pharmaceutical/biomedical preparations / Karakteristike i primena hitozana u farmaceutskim/biomedicinskim preparatima
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Chitosans are binary linear heteropolysaccharides derived from chitin by its partial deacetylation. Due to unique cationic nature these biopolymers have enormous potential in pharmacy and biomedicine. This potential is ...
Konvencionalna medicinska sredstva za obradu rana - osobine i upotreba / Traditional medical devices in wound treatment - characteristics and usage
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Overall, the medical devices used in the treatment of wounds could be divided into traditional dressings, modern dressings (with advanced features), skin replacement products and wound healing devices. This paper provides ...
Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches / Ciljana isporuka antiinflamatornih lekova u donje delove gastrointestinalnog trakta - konvencionalni i savremeni pristupi
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
The therapy of inflammatory bowel diseases can be improved by development of new effective and selective biological drugs and efficiency improvement of existing, traditional anti-inflammatory drugs via targeting sites of ...
Vitamins and minerals in the prevention of disease: The evidence / Vitamini i minerali u prevenciji bolesti - dokazi
(Savez farmaceutskih udruženja Srbije, Beograd, 2009)
A huge number of experimental results and the observations of epidemiological studies have opened wide possibilities of the use of vitamins and minerals in primary and secondary prevention of disease. This kind of health ...
The influence of different formulation factors on physicochemical and biopharmaceutical characteristics of ketoprofen 2,5% gel / Uticaj faktora formulacije na fizičkohemijske i biofarmaceutske karakteristike ketoprofen 2,5% gela
(Savez farmaceutskih udruženja Srbije, Beograd, 2010)
In recent years there has been a growing interest for the development and characterization of vehicles for active pharmaceutical ingredients (API) for semisolid dosage forms. Considering that research efforts applied on ...
Medicines in treatment of addictive disorders / Lekovi u terapiji bolesti zavisnosti
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
It is estimated that annual sales of illegal psychoactive substances account for 8% of total international trade. The large consumption of alcohol and tobacco, as socially accepted drugs, as well as of several classes of ...
The rationale for use of vitamins and minerals in cosmetic products / Opravdanost primene vitamina i minerala u kozmetičkim proizvodima
(Savez farmaceutskih udruženja Srbije, Beograd, 2009)
The paper gives a short description of skin condition attacked by processes of chronological and photoaging, as basic ²indications² for use of vitamins and minerals in different skin care products. Newer literature statements ...
Safety of use of antibacterial drugs / Bezbednost primene antibakterijskih lekova
(Savez farmaceutskih udruženja Srbije, Beograd, 2007)
Selective mechanisms of action, based on the biochemical differences between bacteria and host cells, assure the positive benefit-risk ratios for all antibacterial drugs in current use. On the whole, the adverse effects ...